CERT (Certara) Research & Development: $42.8 Mil (TTM As of Mar. 2026)


CERT Certara Inc CERT
59 GF Score
Price $5.45
GF Value $13.40
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Certara Research & Development?

Certara CERT +0.83% 59 Research & Development is $42.8 Mil as of Mar. 2026. GuruFocus rates CERT with a GF Score™ of 59/100 and a GF Value™ of $13.40 (Possible Value Trap). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Certara's Research & Development for the three months ended in Mar. 2026 was $12.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $42.8 Mil.

Certara  (NAS:CERT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Certara Research & Development Related Terms

Certara Research & Development Historical Data

* Premium members only.

The historical data trend for Certara's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Certara Research & Development Chart

Certara Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 20.38 28.21 34.17 37.11 41.04

Certara Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.52 8.97 10.27 11.28 12.29
CERT
59GF Score
Certara Inc CERT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Certara Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $42.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $42.8 Mil mean?
Certara (CERT) has a Research & Development of $42.8 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Certara and its competitors.
Is Certara's Research & Development too high?
Certara's current Research & Development is $42.8 Mil. Overall, Certara has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Certara's Research & Development compare to TALK and GDRX?
Certara's Research & Development of $42.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Certara and its competitors. Certara's current Research & Development is $42.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Based on GuruFocus' analysis, Certara (CERT) is currently considered Possible Value Trap. The stock's GF Value™ is $13.40, compared to a current price of $5.45 — trading 59.4% below its estimated fair value. The current Research & Development is $42.8 Mil. Certara's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Certara (CERT), the current Research & Development is $42.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Certara (CERT) Overvalued in 2026?

Based on GuruFocus' analysis, Certara stock appears to be undervalued. The current stock price of $5.45 is trading 59.4% below its estimated GF Value™ of $13.40. GuruFocus considers Certara to be Possible Value Trap.

Key valuation signals for CERT:

  • Research & Development: $42.8 Mil
  • GF Value™: $13.40 vs. price of $5.45 (59.4% below fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the CERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Certara Business Description

Address 4 Radnor Corporate Center, Suite 350, Radnor, PA, USA, 19087
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
59GF Score

Get the complete analysis for CERT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.45
Price
$13.40
GF Value